Karl Blom
Directeur/Bestuurslid bij TERRANET AB
Vermogen: 27 708 $ op 31-05-2024
Profiel
Karl Anders Blom is currently the Chairman at Maida Vale Capital AB, Rosland Nordic AB, Black T Quant AB, and holds director positions at Peptonic Medical AB, Emotra AB, Terranet AB, Wonderboo AB, Challengehop, Inc., Hunterhex International Ltd., Hunterhex AB, and Evolutience Pharmaceutical AB.
Previously, he served as the Chief Executive Officer at Nexttobe AB from 2011 to 2015.
He also held director positions at Q-Med AB, Hansa Biopharma AB, BioLamina AB, The Delta Projects AB, Selego AB, and Pharmacia AB.
Additionally, he worked as a Business Controller at Pharmacia AB and as the Chief Financial Officer & Executive Vice President at Vivesto AB from 2017 to 2019.
Mr. Blom has a background in business administration, having obtained undergraduate and Masters degrees from the University of Uppsala.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TERRANET AB CLASS B
0.30% | 31-12-2022 | 2 653 983 ( 0.30% ) | 27 708 $ | 31-05-2024 |
Actieve functies van Karl Blom
| Bedrijven | Functie | Begin |
|---|---|---|
| ALZINOVA AB | Directeur/Bestuurslid | 01-01-2021 |
| EMOTRA AB (PUBL) | Directeur/Bestuurslid | 08-10-2021 |
| TERRANET AB | Directeur/Bestuurslid | 01-09-2022 |
| PEPTONIC MEDICAL AB | Directeur/Bestuurslid | - |
| Evolutience Pharmaceutical AB | Directeur/Bestuurslid | - |
| Black T Quant AB | Voorzitter | - |
| Rosland Nordic AB | Voorzitter | - |
| Challengehop, Inc. | Directeur/Bestuurslid | - |
| Hunterhex AB | Directeur/Bestuurslid | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Eerdere bekende functies van Karl Blom
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░ ░░ | ░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Karl Blom
| University of Uppsala | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| VIVESTO AB | Health Technology |
| ALZINOVA AB | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| TERRANET AB | Technology Services |
| PEPTONIC MEDICAL AB | Health Technology |
| Bedrijven in privébezit | 16 |
|---|---|
| Pharmacia AB | Health Technology |
Maida Vale Capital AB
 Maida Vale Capital AB Investment Banks/BrokersFinance Maida Vale Capital AB is a private company based in Saltsjo-Boo, Sweden. The CEO of the Swedish company is Oliver Aleksov. | Finance |
| Wonderboo AB | |
Emotra AB
 Emotra AB Medical SpecialtiesHealth Technology Emotra AB engages in the research and development of physiological and statistical methods for psychiatric care. It offers a medical device that tests the psychophysiological being of patients suffering from depression through their responses to sound signals. The company was founded by Elizabeth Kaminski and Lars-Håkan Thorell on June 18, 2001 and is headquartered in Molndal, Sweden. | Health Technology |
| Hunterhex International Ltd. | |
| Hunterhex AB | |
| Challengehop, Inc. | |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Finance |
| Skatteverket | |
The Delta Projects AB
 The Delta Projects AB Advertising/Marketing ServicesCommercial Services Part of Principion Holding BV, The Delta Projects AB is a company that provides advertising services. The company is based in Stockholm, Sweden. The Delta Projects was acquired by Principion Holding BV on July 01, 2021. The CEO of the Swedish company is John Marcus Boson Lilja. | Commercial Services |
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
Selego AB
 Selego AB Household/Personal CareConsumer Non-Durables Selego AB manufactures skin care products. The company was founded by Lars Fredriksson in 2013 and is headquartered in Stockholm, Sweden. | Consumer Non-Durables |
| Rosland Nordic AB | |
| Black T Quant AB | |
| Evolutience Pharmaceutical AB |
